Interactions of the protease inhibitor, ritonavir, with common anesthesia drugs
Article
[키워드] administration
adverse effect
affected
Altered
Anesthesia
Antiviral
antiviral drug
approach
Bioavailability
change
changes in
children
clearance
Combination
Comorbidities
Concentration
COVID-19
dependent on
drug
drug clearance
drug dose
Drug interactions
early treatment
enzyme
example
fentanyl
increase in
inhibited
inhibitor
inhibitory
intrinsic
management
metabolic pathways
pathway
Patient
Pharmacodynamics
pharmacokinetic
plasma concentration
propofol
Protease inhibitor
remifentanil
responsible
Ritonavir
subject
Variability
[DOI] 10.1111/pan.14529 PMC 바로가기
[DOI] 10.1111/pan.14529 PMC 바로가기